Topics

Companies Related to "Developing immunotherapeutic treatments emerging viral diseases" [Most Relevant Company Matches] RSS

17:20 EDT 18th July 2019 | BioPortfolio

Here are the most relevant search results for "Developing immunotherapeutic treatments emerging viral diseases" found in our extensive corporate database of over 50,000 company records.

Showing "Developing immunotherapeutic treatments emerging viral diseases" Companies 1–25 of 6,200+

Extremely Relevant

Cavit Sciences

Cavit Sciences, Inc. (“Cavit”) is a biotechnology company engaged in developing treatments of cancer and viral infections. Our strategy is to develop and commercialize intellectual property rights to treat, prevent and inhibit several major diseases including cancers, viral infections and diseases associated with cancers and viral infections. We currently own three patent applicati...


Relevant

Marinomed Biotechnologie GmbH

Marinomed is a biopharmaceutical company discovering and developing innovative anti-viral and immunological treatments. Marinomed develops therapies against respiratory diseases based on its innovative anti-viral respiratory technology platform mavirex. Safety and efficacy of the mavirex technology have already been proven in clinical trials. The huge potential of the technology is reflected by...

NanoViricides, Inc.

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for viral therapy. The Company's novel nanoviricide™ class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. The Company is developing drugs against a number of viral dis...


PsiOxus Therapeutics, Ltd.

PsiOxus Therapeutics is a development stage biotechnology company using non-traditional approaches to develop novel therapeutics that address cancer and other clinically unmet diseases. The Company’s lead candidate is MT-102, a dual action Anabolic Catabolic Transforming Agent (ACTA) in phase II clinical development for the treatment of cachexia and ...

Vivet Therapeutics

Vivet Therapeutics is an emerging biotechnology company developing novel gene therapy treatments for rare, inherited metabolic diseases.

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Memorial Sloan-Kettering Cancer Center, use highly targeted and modular antigen delivery systems that allow the rapid development of a broad range of immunotherapeutic products.

Retrophin, Inc.

Retrophin is a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for focal segmental glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases. The company’s lea...

MeiraGTx

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomi...

MeiraGTx Limited

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomi...

Agenus Inc.

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through co...

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...

Spring Bank Technologies Inc

Spring Bank Technologies (SBT) (the Company) is a biotechnology company located in Milford,Massachusetts. Founded in 2002, the Company is engaged in the discovery and development ofnovel anti-viral therapies against human viral diseases. The Company’s proprietary technologyplatform is built around nucleic acid-based chemistries for the discovery of novel small moleculecompounds that work by sele...

Edison Pharmaceuticals, Inc.

Edison Pharmaceuticals is dedicated to developing treatments for children with rare energy-related diseases. The Company's initial focus is on inherited diseases of the mitochondria. Edison is leveraging insights from those studies to pursue other diseases that share common mechanisms.

Retrophin, LLC

Retrophin, LLC is a privately-held New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for focal segmental glomerulosclerosis, Duchenne Muscular Dystrophy, spinal muscular atrophy, cystic fibrosis and myotubular myopathy. Retrophin's Seri...

Millenia Hope

Millenia Hope is a biopharmaceutical company focused on comprehensive solutions to the problem of world disease. The company’s objective is to fight disease through a portfolio of health products, developed by Millenia Hope and its team of clinical associates based around the world. Millenia Hope utilizes traditional, natural sourced treatments to discover and develop innovative pharmaceuti...

ViroLogic

ViroLogic, a privately held South San Francisco-based biotechnology company, is a leader in the development of novel therapy guidance tools to enable patients, physicians, and medical reimbursers to make rational treatment decisions in the management of viral diseases. The company's proprietary technology is also being used in the fields of viral pharmacogenomics to identify, analyze, and select n...

Virionics Corporation

Virionics Corporation is focused on developing and commercializing a safe and highly effective new antigen delivery platform for prevention and treatment of:Infectious Diseases,Inflammatory Diseases, andCancer.Virionics Corporation is using Virus Like Particles (VLPs) that mimic viral structures to induce a potent immune response resulting in better preventative and therapeutic vaccine products.

Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases. Most anti-infective drugs were designed to block the most prevalent form of a pathogen. Those drugs are doomed to become obsolete due to the emergence of drug-resistant mutations...

VUCCC P/L

VUCCC P/L is an emerging leader in autoimmune & metabolic diseases. The company is involved in commercialising treatments and diagnostic tests in these areas, presenting solutions to real & costly disease problems facing healthcare providers globally.

Globavir Biosciences, Inc.

Globavir Biosciences, based in Los Altos, CA, is developing life-saving technologies for cancer and the diagnosis and treatment of some of the world’s most deadly viral diseases. To complement its world-class dengue diagnostic assays, Globavir is also developing GBV006, a powerful combination drug therapy, for the treatment of dengue fever.

Immtech Pharmaceuticals

Immtech Pharmaceuticals, Inc. is focused on developing and commercializing treatments for infectious diseases in both the developed and developing world, and extending its proprietary medicinal chemistry platform to the treatment of other disorders. Immtech’s mission is to develop and commercialize new treatments for infectious diseases and other disorders with significant unmet needs. We pursue...

Gilead Sciences

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions forpatients and the people who care for them. The Company discovers, develops and commercializes proprietary therapeutics for important viral diseases, including the currently marketed product VISTIDE-Registered Trademark- (cidofovir injection) for the treatment of cytomegalovirus ("CMV") ...

Viron Therapeutics Incorporated

Viron Therapeutics Inc. is an emerging biotechnology company developing novel anti-inflammatory therapeutics. Viron was founded in 1997 as a spin-off of The John P. Robarts Research Institute in London, Canada. The company has developed its unique platform of viral proteins into a pipeline of therapeutic products with a clear path to the marketplace.

Ology Bioservices, Inc.

Ology Bioservices, Inc. (formerly Nanotherapeutics, Inc.) is a biologics-focused contract development and manufacturing organization (CDMO) serving both government and commercial clients. The Company’s capabilities include a pilot facility for performing optimization of upstream, downstream and formulation functions, bulk cGMP manufacturing including ...

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’s Mission Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving ...


More From BioPortfolio on "Developing immunotherapeutic treatments emerging viral diseases"

Quick Search

Corporate Database Quicklinks